1. Home
  2. IFBD vs TOVX Comparison

IFBD vs TOVX Comparison

Compare IFBD & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

N/A

Current Price

$0.94

Market Cap

8.4M

Sector

Technology

ML Signal

N/A

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.20

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFBD
TOVX
Founded
2001
2001
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.3M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
IFBD
TOVX
Price
$0.94
$0.20
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
16.2K
2.8M
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,861,442.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1520.48
N/A
52 Week Low
$0.88
$0.17
52 Week High
$2.70
$2.08

Technical Indicators

Market Signals
Indicator
IFBD
TOVX
Relative Strength Index (RSI) 45.33 38.79
Support Level $0.90 $0.17
Resistance Level $1.04 $0.24
Average True Range (ATR) 0.07 0.02
MACD 0.00 -0.00
Stochastic Oscillator 17.01 24.56

Price Performance

Historical Comparison
IFBD
TOVX

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: